Aihong Wang

984 total citations
40 papers, 740 citations indexed

About

Aihong Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Aihong Wang has authored 40 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Aihong Wang's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (5 papers) and Immune Cell Function and Interaction (5 papers). Aihong Wang is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (5 papers) and Immune Cell Function and Interaction (5 papers). Aihong Wang collaborates with scholars based in China, United States and Australia. Aihong Wang's co-authors include Canhui Jin, Gongping Wang, Hongyu Li, J. Anthony Ware, Sybill Patan, Motohiro Nomura, Guangshuai Li, Qiaohong Qin, Sai Han and Youzhong Zhang and has published in prestigious journals such as Circulation Research, Annals of Oncology and Journal of Cellular Physiology.

In The Last Decade

Aihong Wang

38 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aihong Wang China 16 513 338 143 100 46 40 740
Stephany Corrêa Brazil 13 432 0.8× 209 0.6× 209 1.5× 76 0.8× 48 1.0× 27 670
Wuguo Li China 16 569 1.1× 272 0.8× 192 1.3× 85 0.8× 78 1.7× 31 842
Seshagiri Duvvuri United States 9 657 1.3× 380 1.1× 144 1.0× 61 0.6× 40 0.9× 15 875
Maoxiao Feng China 14 509 1.0× 294 0.9× 131 0.9× 74 0.7× 59 1.3× 24 720
Chuanyong Zhang China 13 382 0.7× 231 0.7× 156 1.1× 125 1.3× 49 1.1× 25 630
Guanhong Luo China 15 608 1.2× 383 1.1× 142 1.0× 49 0.5× 41 0.9× 23 764
Naser Jafari United States 17 424 0.8× 262 0.8× 87 0.6× 79 0.8× 58 1.3× 25 670
Qianqian Lei China 16 514 1.0× 333 1.0× 213 1.5× 145 1.4× 82 1.8× 39 831
Yi-Chu Lin United States 6 382 0.7× 262 0.8× 124 0.9× 135 1.4× 33 0.7× 14 665
Filipa Lopes‐Coelho Portugal 11 358 0.7× 251 0.7× 135 0.9× 62 0.6× 79 1.7× 17 634

Countries citing papers authored by Aihong Wang

Since Specialization
Citations

This map shows the geographic impact of Aihong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aihong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aihong Wang more than expected).

Fields of papers citing papers by Aihong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aihong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aihong Wang. The network helps show where Aihong Wang may publish in the future.

Co-authorship network of co-authors of Aihong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Aihong Wang. A scholar is included among the top collaborators of Aihong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aihong Wang. Aihong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yingying, et al.. (2025). Fatal Pulmonary Embolism Secondary to Heparin‐Induced Thrombocytopenia in Hemodialysis: A Case Study. Hemodialysis International. 30(1). 288–290.
2.
Shen, Yifan, Zhen Li, Suying Lü, et al.. (2024). 640P Exploratory ctDNA analyses from first-in-human phase I trial of D3S-001 in patients with advanced solid tumor harboring a KRAS G12C mutation. Annals of Oncology. 35. S1642–S1643. 1 indexed citations
3.
Yang, Guang, Zhi‐Wei Lai, Fengping Zheng, et al.. (2024). COVID-19 increases extracorporeal coagulation during hemodialysis associated with upregulation of vWF/FBLN5 signaling in patients with severe/critical symptoms. BMC Infectious Diseases. 24(1). 427–427. 5 indexed citations
4.
Wang, Aihong, et al.. (2023). FTO promotes the progression of cervical cancer by regulating the N6‐methyladenosine modification of ZEB1 and Myc. Molecular Carcinogenesis. 62(8). 1228–1237. 12 indexed citations
5.
Jin, Canhui, Tianbao Wang, Yanhui Yang, et al.. (2023). Rational targeting of autophagy in colorectal cancer therapy: From molecular interactions to pharmacological compounds. Environmental Research. 227. 115721–115721. 5 indexed citations
6.
Liu, Lu, Aihong Wang, Xiaoli Liu, et al.. (2022). Blocking TIGIT/CD155 signalling reverses CD8+ T cell exhaustion and enhances the antitumor activity in cervical cancer. Journal of Translational Medicine. 20(1). 280–280. 56 indexed citations
7.
Wang, Ying, Xiaoli Liu, Aihong Wang, et al.. (2021). Cervical cancer-derived exosomal miR-663b promotes angiogenesis by inhibiting vinculin expression in vascular endothelial cells. Cancer Cell International. 21(1). 684–684. 26 indexed citations
8.
Liu, Lu, Ying Wang, Geng Chen, et al.. (2021). CD155 Promotes the Progression of Cervical Cancer Cells Through AKT/mTOR and NF-κB Pathways. Frontiers in Oncology. 11. 655302–655302. 15 indexed citations
9.
Wei, Liuya, Yang Yang, Pranav Gupta, et al.. (2020). A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT Pathway. Molecular Therapy — Oncolytics. 18. 137–148. 11 indexed citations
10.
Wang, Aihong, et al.. (2019). Multicenter research on tumor and pregnancy outcomes in patients with early-stage cervical cancer after fertility-sparing surgery. Journal of International Medical Research. 47(7). 2881–2889. 16 indexed citations
11.
Chen, Bin, Qi Dai, Qun Zhang, et al.. (2019). The relationship among occupational irradiation, DNA methylation status, and oxidative damage in interventional physicians. Medicine. 98(39). e17373–e17373. 15 indexed citations
12.
Wang, Aihong, et al.. (2019). Effects of the health belief model following acute exacerbation of chronic obstructive pulmonary disease in a hospital in China. Journal of Thoracic Disease. 11(8). 3593–3598. 6 indexed citations
13.
Wang, Aihong, et al.. (2018). LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway. International Journal of Biological Macromolecules. 120(Pt B). 1705–1713. 71 indexed citations
14.
15.
Zhang, Zuwen, et al.. (2017). An in vitro study on the effects of the combination of salinomycin with cisplatin on human gastric cancer cells. Molecular Medicine Reports. 16(2). 1031–1038. 6 indexed citations
16.
Zhang, Zuwen, et al.. (2017). Effects of salinomycin and 17-AAG on proliferation of human gastric cancer cells in vitro. Molecular Medicine Reports. 16(2). 1063–1070. 4 indexed citations
17.
18.
Huang, Xiaoqin, et al.. (2013). A multi-spectroscopic approach to investigate the interaction of prodigiosin with ct-DNA. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 123. 497–502. 42 indexed citations
19.
Wang, Aihong & Lishi Zhang. (2007). [Effect of lycopene on the proliferation of MCF-7 and MDA-MB-231 cells].. PubMed. 38(6). 958–60, 976. 5 indexed citations
20.
Wang, Aihong & Jui H. Wang. (1999). Effective Treatment of Murine Leukemia with Antisense Poly-2′-O-(2,4-Dinitrophenyl)-O1igoribonucleotides. Antisense and Nucleic Acid Drug Development. 9(1). 43–51. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephany Corrêa Breakdown of academic impact, for papers by Wuguo Li Breakdown of academic impact, for papers by Seshagiri Duvvuri Breakdown of academic impact, for papers by Maoxiao Feng Breakdown of academic impact, for papers by Chuanyong Zhang Breakdown of academic impact, for papers by Guanhong Luo Breakdown of academic impact, for papers by Naser Jafari Breakdown of academic impact, for papers by Qianqian Lei Breakdown of academic impact, for papers by Yi-Chu Lin Breakdown of academic impact, for papers by Filipa Lopes‐Coelho
Rankless by CCL
2026